Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
Intensive chemotherapy is associated with significant thrombocytopenia, often requiring
platelet transfusion to maintain platelet counts. This investigational drug has demonstrated
the ability to increase platelet counts. This study will test the safety and efficacy of this
investigational drug in the prevention of thrombocytopenia in patients with solid tumors,
lymphomas or multiple myeloma who are receiving myelosuppressive treatment regimens requiring
platelet transfusion support.